Insulet Corporation (PODD) Discusses Recent Product Recalls and Physician Community Response at ADA Meeting TranscriptSeeking Alpha • 06/12/26
Insulet to Spotlight New Data and Innovations Demonstrating How Omnipod® Simplifies Diabetes Management and Delivers Strong Clinical Outcomes at the American Diabetes Association 86th Scientific SessionsBusiness Wire • 06/04/26
Insulet Corporation (PODD) Presents at 46th Annual William Blair Growth Stock Conference TranscriptSeeking Alpha • 06/03/26
Insulet Announces U.S. Rollout of Enhanced Omnipod® 5 Algorithm and Expands Compatibility with Abbott's FreeStyle Libre 3 Plus SensorBusiness Wire • 06/03/26
US court overturns Insulet's $452 mln insulin-pump trade secret verdict against EOFlowReuters • 05/28/26
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International MarketsBusiness Wire • 05/26/26
These 15 S&P 500 stocks could be contrarian ways to play the market's uneven rallyMarket Watch • 05/20/26
Insulet Corporation (PODD) Presents at Bank of America Global Healthcare Conference 2026 TranscriptSeeking Alpha • 05/13/26
Insulet (PODD) Loses 17.3% in 4 Weeks, Here's Why a Trend Reversal May be Around the CornerZacks Investment Research • 05/06/26
Insulet lifts annual revenue forecast after quarterly beat on strong insulin pump demandReuters • 05/06/26
Insulet Unveils 2025 Sustainability Report Highlighting Strong Momentum Across Key PrioritiesBusiness Wire • 05/05/26